Thymosin ALPHA-1

Simonova MA, Ivanov I, Shoshina NS, Komyakova AM, Makarov DA, Baranovskii DS, et al.

International journal of molecular sciences

A 2025 review synthesizes preclinical and mechanistic literature on thymosin alpha-1 in models of age-related thymic involution and immune decline, describing how the peptide modulates T-cell differentiation pathways and dendritic-cell/macrophage activity through its immunomodulatory, anti-inflammatory, and antioxidant properties, and profiles a TNF-alpha/thymosin-alpha-1 fusion peptide construct studied preclinically for combined immunomodulatory and antitumor signaling with reduced toxicity in animal models.

King R, Tuthill C

Vitamins and hormones

This review details thymosin alpha-1's origin as a thymic-tissue-derived peptide that restored immune-cell populations in thymectomized mouse models, and describes its receptor pharmacology: activation of Toll-like receptor signaling in myeloid and plasmacytoid dendritic cells that triggers downstream cytokine-production pathways.

King R, Tuthill C

Vitamins and Hormones

This review summarizes thymosin alpha-1’s pleiotropic immunomodulatory mechanism: acting through Toll-like receptors in myeloid and plasmacytoid dendritic cells to activate signaling pathways and drive immune-related cytokine production, with effects characterized across multiple immune-cell subsets in preclinical models.

Naylor PH, Hadden JW

Annals of the New York Academy of Sciences

This paper reports that combining a cytokine-based biologic (IRX-2) with thymosin alpha-1 increased T-cell numbers during recovery from hydrocortisone-induced immune suppression in mice, and further reduced tumor burden compared to IRX-2 alone in mice that received chemotherapy -- preclinical immune-recovery and tumor-burden endpoints observed in a rodent model.

Hu SK, Low TL, Goldstein AL

Molecular and cellular biochemistry

This foundational study from the peptide's discovery group characterizes thymosin alpha-1 (isolated from bovine thymosin fraction 5, MW approximately 3108) as a modulator of terminal deoxynucleotidyl transferase activity -- an enzyme marker of immature T-cell populations -- in murine thymocyte and immunosuppressed-mouse models, establishing its role in regulating early- and late-stage T-cell differentiation.